Which Factors Will Push The Outpatient Oncology Infusion Market To Achieve $18.81 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
#What Is The Present And Forecasted Size Of The Outpatient Oncology Infusion Market?#_x000D_
Over the past few years, the outpatient oncology infusion market has seen significant growth. The market size, which stood at $12.99 billion in 2024, is projected to expand to $14.02 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 7.9%. Factors driving growth in this historic period include an increase in cancer cases, more outpatient centers, a preference among patients for environments resembling their homes, greater insurance coverage, a shift from inpatient care to outpatient care, and higher survival rates._x000D_
_x000D_
Anticipations suggest a significant expansion in the outpatient oncology infusion market in the upcoming years. The market size is projected to escalate to $18.81 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this projected growth include an increasing elderly population, a surge in demand for individualized medication, the rising use of biosimilars, a pursuit for cost efficiency, the introduction of value-based reimbursement models, and a shortage of healthcare professionals. Key trends in the predicted period encompass breakthroughs in infusion apparatus, the incorporation of telehealth services, the advent of technology-powered remote patient supervision, evolution in personalized medications, and innovative developments in targeted treatments._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp_x000D_
_x000D_
#What Underlying Factors Are Supporting The Outpatient Oncology Infusion Market Growth?#_x000D_
The escalating number of cancer incidences is anticipated to boost the expansion of the outpatient oncology infusion market in the future. Cancer, categorized by uncontrollable growth of atypical cells that potentially intrude into surrounding body tissues and disseminate to other body parts, is becoming increasingly prevalent, largely due to the global aging populations. This is because the chances of cancer development considerably increase with age. Outpatient oncology infusion enables cancer treatments such as chemotherapy, immunotherapy, or targeted therapy to be administered in a clinical setting without the need for hospitalization. This method lets patients continue their regular daily activities while receiving treatment. As an example, Macmillan Cancer Support, a charity from the UK that offers practical, emotional, and financial aid to those affected by cancer, estimated that the population of people living with cancer in the UK, which currently exceeds 3 million, is expected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040, as predicted in April 2024. Consequently, the steadily rising cancer incidences are fueling the growth of the outpatient oncology infusion market._x000D_
_x000D_
#How Does The Outpatient Oncology Infusion Market Differ By Segment?#_x000D_
The outpatient oncology infusion market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors_x000D_
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy_x000D_
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers_x000D_
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings_x000D_
_x000D_
Subsegments:_x000D_
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps_x000D_
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets_x000D_
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas_x000D_
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors_x000D_
_x000D_
#What New Opportunities Are Emerging From Trends In The Outpatient Oncology Infusion Market?#_x000D_
Leading companies in the outpatient oncology infusion market are prioritizing the creation of ground-breaking products like syringe infusion pumps. These aids are designed to boost infusion precision, enhance the safety of patients, and modernize the delivery of medication through cutting-edge software and dose miscalculation reduction mechanisms. A motorized device, more commonly known as a syringe driver, is created to meticulously manage the movement of liquids by mechanically directing the plunger of a syringe either forward or backward. For example, Baxter International Inc., a health organization out of the U.S with expertise in surgical and intravenous infusion innovations, was granted authorization from the U.S. Food and Drug Administration (FDA) in August 2022 for their Novum IQ Syringe Infusion Pump (SYR). This system incorporates the Dose IQ Safety Software of Baxter’s, leveraging the advanced, accessible online Dose IQ platform equipped with a modifiable drug library and a mechanism for dose error reduction. This was developed to assist clinicians and healthcare institutions by centralizing immediate access to current medication information. Specifically designed for outpatient healthcare situations, like outpatient oncology infusion environments, this system offers precise, programmable infusions of therapeutic agents across a wide range of clinical care settings._x000D_
_x000D_
#Who Are The Global Leaders Steering The Outpatient Oncology Infusion Market Forward?#_x000D_
Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
_x000D_
#Which Region Is Likely To Register The Fastest Growth In The Outpatient Oncology Infusion Market?#_x000D_
North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp_x000D_
_x000D_
Browse Through More Reports Similar to the Global Outpatient Oncology Infusion Market 2025, By The Business Research Company_x000D_
_x000D_
Oncology Drugs Global Market Report 2025_x000D_
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market_x000D_
_x000D_
Intravenous Infusion Pumps Global Market Report 2025_x000D_
_x000D_
Generic Oncology Sterile Injectable Global Market Report 2025_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
